1Ruiz-Gonzalez A, Falguera M,Nogues A, et al. Is streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia.Am J Med, 1999, 106:385-390.
2Niederman MS, Mandell LA, Anzueto A, et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med, 2001,163:1730-1754.
4Davies BI, Maesen FP. Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity. J Antimicrob Chemother, 1999, 43 Supple C:83-90.
5DeAbate CA, Russell M, et al. Safety and efficacy if oral levofloxacin versus cefuroxime axetil in acute bacterial exacerbations of chronic bronchitis. Respir Care, 1999, 42:206-213.
6Ramirez A, Molina J, et al. Gatifloxacin treatment in patients with acute exacerbation of chronic bronchitis: clinical trial results. J Respir Dis, 1999, 20: S 30-39.
7File TM Jr, Segreti J, Dunbar L,et al. A multi-center, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired penumonia, Antimicrob Agents Chemother, 1997, 41:1965-1972.
8Fogarty C, Ramirez L.Efficacy and safety of moxifloxacin VS clarithomycin for community-acqured pneumonia. Infec Med, 1999, 16:748-763.
9Ramirez J A, Mgayen T.Treating community-acqured pneumonia with once- daily gatifloxacin VS twice-daily clarithromycin. J Respir Dis, 1999, 20:s60-69.
2Bamonte F,Dionisotti S,Gamba M,et al.Relation of dosing regimen to aminoglycoside ototoxicity: evaluation of auditory damage in the guinea pig[].Journal of Chemotherapy.1990
3Gilbert DN.Once-daily aminoglycoside therapy[].Antimicrobial Agents and Chemotherapy.1991
4Wood CA,Norton DR,Kohlhepp SJ,et al.The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess[].The Journal of Infectious Diseases.1988
